Beclin 1 prevents ISG15-mediated cytokine storms to secure fetal hematopoiesis and survival
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci177375 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Wen Wei und 23 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Blood Engineering and Manufacturing, Cyrus Tang Medical Institute, Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Hematopoiesis, Cytokines, Beclin-1, Ubiquitins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Proper control of inflammatory responses is essential for embryonic development, but the underlying mechanism is poorly understood. Here, we show that under physiological conditions, inactivation of ISG15, an inflammation amplifier, is associated with the interaction of Beclin 1 (Becn1), via its evolutionarily conserved domain, with STAT3 in the major fetal hematopoietic organ of mice. Conditional loss of Becn1 caused sequential dysfunction and exhaustion of fetal liver hematopoietic stem cells, leading to lethal inflammatory cell-biased hematopoiesis in the fetus. Molecularly, the absence of Becn1 resulted in the release of STAT3 from Becn1 tethering and subsequent phosphorylation and translocation to the nucleus, which in turn directly activated the transcription of ISG15 in fetal liver hematopoietic cells, coupled with increased ISGylation and production of inflammatory cytokines, whereas inactivating STAT3 reduced ISG15 transcription and inflammation but improved hematopoiesis potential, and further silencing ISG15 mitigated the above collapse in the Becn1-null hematopoietic lineage. The Becn1/STAT3/ISG15 axis remains functional in autophagy-disrupted fetal hematopoietic organs. These results suggest that Becn1, in an autophagy-independent manner, secures hematopoiesis and survival of the fetus by directly inhibiting STAT3/ISG15 activation to prevent cytokine storms. Our findings highlight a previously undocumented role of Becn1 in governing ISG15 to safeguard the fetus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center for Blood Engineering and Manufacturing, Cyrus Tang Medical Institute, Soochow University, Suzhou, China.
- National Clinical Research Center for Hematologic Diseases, Key Laboratory of Thrombosis and Hemostasis Ministry of Health, Collaborative Innovation Center of Hematology, Jiangsu Institute of Hematology, Institute of Bl…
- State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, China.
- The Ninth Affiliated Suzhou Hospital of Soochow University, Suzhou, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wei, W., Gao, X., Qian, J., Li, L., Zhao, C., Xu, L., Zhu, Y., Liu, Z., Liu, N., Wang, X., Jin, Z., Liu, B., Xu, L., Dong, J., Zhang, S., Wang, J., Zhang, Y., Yu, Y., Yan, Z., …, & Wang, J. (2025). Beclin 1 prevents ISG15-mediated cytokine storms to secure fetal hematopoiesis and survival. Journal of Clinical Investigation. https://doi.org/10.1172/jci177375
Vancouver
Wei W, Gao X, Qian J, Li L, Zhao C, Xu L, et al. Beclin 1 prevents ISG15-mediated cytokine storms to secure fetal hematopoiesis and survival. Journal of Clinical Investigation. 2025. doi:10.1172/jci177375
BibTeX
@article{Wei2025,
author = {Wei, Wen and Gao, Xueqin and Qian, Jiawei and Li, Lei and Zhao, Chen and Xu, Li and Zhu, Yanfei and Liu, Zhenzhen and Liu, Nengrong and Wang, Xueqing and Jin, Zhicong and Liu, Bowen and Xu, Lan and Dong, Jin and Zhang, Suping and Wang, Jiarong and Zhang, Yumu and Yu, Yao and Yan, Zhanjun and Yang, Yanjun and Lu, Jie and Fang, Yixuan and Yuan, Na and Wang, Jianrong},
title = {Beclin 1 prevents ISG15-mediated cytokine storms to secure fetal hematopoiesis and survival},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci177375}
}
EUVIMED